К вопросу о применении дабигатрана при персистирующей фибрилляции предсердий
Антон Владимирович Барсуков, Глуховской Дмитрий Владимирович, М. П. Зобнина et al. · Complex Issues of Cardiovascular Diseases · 2012
The article highlights the prevention of thromboembolic events in patients with atrial fibrillation. The clinical case is presented and focused on direct thrombin inhibitor dabigatran administration as a secondary prevention strategy of thromboembolism (of an arrhythmogenic origin)
Cited by 0 works.